NCT00197444View on ClinicalTrials.gov

Low-Dose Nedaplatin (CDGP:Cis-Diammine-Glycolatoplatinum)/5-FU Combined With Radiation for Esophageal Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

33

Participants

Timeline

Start Date

January 31, 2003

Primary Completion Date

September 30, 2008

Study Completion Date

December 31, 2008

Conditions
Esophageal CancerSquamous Cell Carcinoma
Interventions
DRUG

CDGP/5-FU combined with radiation

Low-dose of Nedaplatin (CDGP) 10 mg/body/day was daily administered on day 1-5, 8-13, 15-19, 22-26 and 5-FU 500 mg/body/day was continuously administered on day 1-5, 8-13, 15-19, 22-26.

RADIATION

Radiotherapy

Fractionated external radiotherapy was performed from the first day of chemotherapy and a total dose of 50.4-66 Gy was delivered at the rate of 1.8-2.0 Gy per fraction.

Trial Locations (1)

431-3192

First Department of Medicine, Hamamatsu University School of Medicine, Hamamatsu

All Listed Sponsors
lead

Hamamatsu University

OTHER

NCT00197444 - Low-Dose Nedaplatin (CDGP:Cis-Diammine-Glycolatoplatinum)/5-FU Combined With Radiation for Esophageal Cancer | Biotech Hunter | Biotech Hunter